Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics
Merit Medical Systems, Inc. (MMSI)
Today's Latest Price: $46.56 USD
Updated Aug 13 5:20pm
Add MMSI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 133 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
MMSI Stock Summary
- MMSI's went public 28.48 years ago, making it older than 81.6% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for MMSI is currently 21.78, higher than 79.98% of US stocks with positive operating cash flow.
- Over the past twelve months, MMSI has reported earnings growth of -144.1%, putting it ahead of just 13.45% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Merit Medical Systems Inc, a group of peers worth examining would be MSA, XRX, XYL, SYK, and HRC.
- MMSI's SEC filings can be seen here. And to visit Merit Medical Systems Inc's official web site, go to www.merit.com.
MMSI Stock Price Chart Technical Analysis Charts
MMSI Price/Volume Stats
| Current price | $46.56 | 52-week high | $47.99 |
| Prev. close | $45.27 | 52-week low | $19.50 |
| Day low | $44.99 | Volume | 281,961 |
| Day high | $46.64 | Avg. volume | 537,426 |
| 50-day MA | $43.92 | Dividend yield | N/A |
| 200-day MA | $36.85 | Market Cap | 2.58B |
Merit Medical Systems, Inc. (MMSI) Company Bio
Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.
MMSI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $46.56 | $16.03 | -64% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Merit Medical Systems Inc. To summarize, we found that Merit Medical Systems Inc ranked in the 24th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 63.5%. In terms of the factors that were most noteworthy in this DCF analysis for MMSI, they are:
- Merit Medical Systems Inc's effective tax rate, as measured by taxes paid relative to net income, is at 24 -- greater than 86.48% of US stocks with positive free cash flow.
- Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.06. This coverage rate is greater than that of only 16.23% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- The weighted average cost of capital for the company is 10. This value is greater than 82.68% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -64% |
| 1% | -64% |
| 2% | -64% |
| 3% | -63% |
| 4% | -63% |
| 5% | -63% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MMSI, try ENTA, HSIC, SNN, HAPP, and HOLX.
Loading social stream, please wait...